Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.

ABSTRACT: Respiratory diseases are leading causes of death and disability in developing and developed countries. The burden of acute and chronic respiratory diseases has been rising throughout the world and represents a major problem in the public health system. Acute respiratory diseases include pneumonia, influenza, SARS-CoV-2 and MERS viral infections; while chronic obstructive pulmonary disease (COPD), asthma and, occupational lung diseases (asbestosis, pneumoconiosis) and other parenchymal lung diseases namely lung cancer and tuberculosis are examples of chronic respiratory diseases. Importantly, chronic respiratory diseases are not curable and treatments for acute pathologies are particularly challenging. For that reason, the integration of nanotechnology to existing drugs or for the developme

SUBMITTER: Ibarra-Sanchez LA 

PROVIDER: S-EPMC8896872 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature